Can You Get Medical Cannabis on the NHS in 2026? The Honest Answer

Medical cannabis has been legal in the UK since November 2018.

In theory, this means it should be available on NHS prescription.

In practice, fewer than 100 NHS prescriptions have been issued since legalisation — out of an estimated 1.4 million UK patients who self-medicate with illegal cannabis.

This guide explains why NHS access is so limited, when the NHS will prescribe, and what your options are if you cannot get an NHS prescription.

When Will the NHS Prescribe Medical Cannabis? The NHS will only prescribe cannabis-based medicines in very specific circumstances.

According to NHS guidelines: Sativex (nabiximols) — A THC:CBD mouth spray — may be prescribed for MS-related spasticity when other treatments have not been effective.

This is the most commonly prescribed cannabis-based medicine on the NHS.

Nabilone — A synthetic cannabinoid — may be prescribed for severe nausea and vomiting caused by chemotherapy, when other anti-sickness treatments have not worked.

Epidyolex (CBD) — A purified CBD oil — may be prescribed for severe epilepsy syndromes including Dravet syndrome and Lennox-Gastaut syndrome, and more recently for tuberous sclerosis complex.

For all other conditions — including chronic pain, anxiety, depression, PTSD, insomnia, and fibromyalgia — the NHS does not routinely prescribe cannabis-based medicines.

This is despite significant clinical evidence and thousands of patient success stories.

Why Is NHS Access So Restricted? Several factors limit NHS access to medical cannabis: Lack of clinical trial evidence — The NHS only approves treatments backed by large randomised controlled trials.

While there is substantial real-world evidence for cannabis in conditions like chronic pain, the formal trial evidence does not yet meet NHS thresholds.

Cost — Medical cannabis is expensive, and NHS budgets are finite.

A course of NHS-approved cannabis medicine can cost thousands of pounds per year, which clinical commissioning groups (CCGs) are reluctant to fund.

Prescriber responsibility — NHS doctors are personally responsible for their prescribing decisions.

Many are reluctant to prescribe cannabis-based products outside established guidelines due to concerns about liability.

Lack of NICE approval — The National Institute for Health and Care Excellence (NICE) has not recommended cannabis-based medicines for most conditions beyond the narrow indications above.

Without NICE approval, CCGs are not obligated to fund prescriptions.

The result is that the overwhelming majority of UK patients who benefit from medical cannabis pay privately.

Private Medical Cannabis — Your Only Realistic Option Since 2019, over 30 private clinics have opened to meet the demand the NHS is not serving.

Private prescriptions are legal as long as they are issued by a specialist doctor on the GMC Specialist Register.

All UK private cannabis clinics operate outside the NHS.

This means: All costs are paid privately Any patient assessed as suitable by a specialist doctor can receive a prescription Consultations are typically conducted by video call Medication is delivered by post from licensed pharmacies Private vs NHS — What Is the Difference? The medical cannabis product itself is identical whether prescribed privately or on the NHS.

Both are sourced from licensed UK producers and imported from EU-GMP certified facilities.

Both must meet the same quality and safety standards.

The differences are: Cost — NHS prescriptions are theoretically free at point of use (paid through general taxation).

Private prescriptions cost between £1,200 and £5,000 per year.

Conditions — NHS restricts prescribing to a narrow list.

Private clinics assess each patient individually and may prescribe for a much broader range of conditions.

Waiting times — NHS specialist appointments can take months.

Private clinics often offer appointments within days.

Product choice — NHS prescriptions are limited to products approved by the local CCG.

Private clinics have access to a wider range of products across multiple pharmacies.

Has Anything Changed Since Legalisation? Despite the 2018 legalisation, very little has changed for patients seeking NHS prescriptions.

The number of NHS prescriptions issued remains in the dozens, not the millions that some anticipated.

Several attempts have been made to improve access: Project TWENTY21 — A registry study by Drug Science designed to build real-world evidence for cannabis prescribing.

Participating clinics offered reduced-cost consultations to patients, with all data contributed to the registry.

The project completed in 2023.

All-Party Parliamentary Group — Multiple cross-party groups have called for improved NHS access to medical cannabis, particularly for children with severe epilepsy.

Little concrete policy change has resulted.

Cannabis Industry Council — A trade body representing clinics, pharmacies, and producers, working to improve patient access and address regulatory barriers.

No direct policy change.

The NHS has stated that wider access will only become possible when there is sufficient clinical evidence and guidance from NICE.

This remains the official position as of 2026.

What to Do If You Cannot Get an NHS Prescription The honest answer is that most patients who want medical cannabis in the UK will need to go private.

The good news is that private access is: Legal — fully licensed specialist doctors on the GMC register Accessible — clinics across the UK, appointments available within days Affordable — initial consultations from £0 to £299, ongoing costs from £1,200/year Effective — thousands of UK patients have found relief through private prescriptions The first step is to complete a free eligibility check with a private clinic.

This takes 2-5 minutes and does not commit you to anything.